6947-81-5

Usage

Uses

Used in Pharmaceutical Industry:
4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID is used as an analgesic for the relief of mild to moderate pain associated with conditions such as headaches, muscle aches, menstrual cramps, and dental pain. Its ability to alleviate pain is attributed to its capacity to reduce prostaglandin synthesis, thereby decreasing the sensation of pain.
Used in Antipyretic Applications:
In the pharmaceutical industry, 4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID is utilized as an antipyretic to reduce fever. It achieves this by normalizing body temperature through the inhibition of prostaglandin production, which plays a role in thermoregulation.
Used in Anti-inflammatory Applications:
4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID is also used as an anti-inflammatory agent to treat inflammation caused by various conditions such as arthritis, sprains, and strains. By inhibiting the production of prostaglandins, it helps to decrease swelling and redness associated with inflammation.
Used in Over-the-Counter Medications:
4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID is used as an active ingredient in over-the-counter medications for the self-treatment of minor aches, pains, and fevers. Its widespread availability allows individuals to manage common discomforts without a prescription.
Used in Prescription Strength Formulations:
For more severe or chronic conditions, 4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID is used in prescription strength formulations, providing a higher dosage to address more intense pain and inflammation under medical supervision.

InChI:InChI=1/C13H16O3/c1-9(2)10-3-5-11(6-4-10)12(14)7-8-13(15)16/h3-6,9H,7-8H2,1-2H3,(H,15,16)

Upstream product

• 98-82-8 Isopropylbenzene 
• 14794-31-1 ethyl 3-(chloroformyl)propionate 
• 108-30-5 succinic acid anhydride 

Downstream Products

• 7501-37-3 4-(4-isopropylphenyl)butanoic acid 
• 854672-90-5 3-bromo-4-(4-isopropyl-phenyl)-4-oxo-butyric acid 
• 7501-40-8 1-Methyl-7-isopropyl-1,2,3,4-tetrahydronaphthalin-1-ol 
• 1627186-18-8 4-benzyl-2,3,3a,4-tetrahydro-3a-(4-isopropylphenyl)pyrrolo[1,2-a]quinazoline-1,5-dione 
• 1627186-23-5 4-(4-methoxybenzyl)-2,3,3a,4-tetrahydro-3a-(4-isopropylphenyl)pyrrolo[1,2-a]quinazoline-1,5-dione 
• 1082600-70-1 C₁₃H₂₀O 
• 150074-76-3 1-(4-iso-Propylphenyl)-butane-1,4-diol 
• 716371-76-5 [4-(4-isopropyl-phenyl)-2-methyl-thiazol-5-yl]-acetic acid 
• 106541-63-3 methyl (4-isopropylphenyl)-3-methyl-butanoate 
• 106541-61-1 4-(4-Isopropyl-phenyl)-3-methyl-4-oxo-butyric acid 
• 106541-60-0 3-(4-isopropylbenzoyl)-3-butenoic acid 

Relevant academic research and scientific papers

Organoselenium-catalyzed synthesis of oxygen- and nitrogen-containing heterocycles

A new and efficient approach for the synthesis of oxygen and nitrogen heterocycles by organoselenium catalysis has been developed. The exo-cyclization proceeded smoothly under mild conditions with good functional group tolerance and excellent regioselectivity. Mechanistic studies revealed that 1-fluoropyridinium triflate is key for oxidative cyclization.

Iron-catalyzed arene alkylation reactions with unactivated secondary alcohols

A simple, iron-based catalytic system allows for the inter- and intramolecular arylation of unactivated secondary alcohols. This transformation expands the substrate scope beyond the previously required activated alcohols and proceeds under mild reaction conditions, tolerating air and moisture. Furthermore, the use of an enantioenriched secondary alcohol provides an enantioenriched product for the intramolecular reaction, thereby offering a convenient approach to nonracemic products.

NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS

The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacte

Asymmetric synthesis of 2-aryl-5-oxotetrahydrofuran-2-carboxylic acids

3-Aryl-2-hydroxycyclopent-2-en-1-ones, when subjected to asymmetric oxidation, result in enantiomerically enriched 2-aryl-5-oxotetrahydrofuran-2- carboxylic acids. Electron-donating substituents in the para position of the phenyl ring increase the yield and decrease the enantioselectivity of the process. Georg Thieme Verlag Stuttgart.

Process for the production of cyclic sulfonium salts

A process for the production of a 5-7 membered ring cyclic sulfonium salt compound, including a 5-7 membered ring cyclic sulfonium salt compound having a non-nucleophilic anion, is described. Members of the latter group are potentially useful as initiators for cationic polymerizations. The process comprises reacting a 1.4-, 1.5-, or 1.6-diol compound or a 5-7 membered ring cyclic ether compound with a mercapto compound and a strong protonic acid yielding the cyclic sulfonium salt compound. Some compounds described are also novel compounds per se.

N-disubstituted cycloalkylmethyl amines useful as fungicides

Compounds having plant fungicidal properties are of formula: and stereoisomers thereof, wherein R1 and R2, each represent a hydrogen atom, a halogen atom, or an alkyl group containing from 1 to 4 carbon atoms, R3 and Rsub

9-Methylenelongibornane: Lewis Acid-induced Transannular Hydride Shift/Rearrangement to 9-Methylisolongifolene/7-Isopropyl-1,1,3-trimethyltetralin

9-Methyllongibornyl-9-cation (5, R=Me) generated from 9-methylenelongibornane (2), on exposure to BF3*OEt2 in benzene, has been shown to undergo a transannular 1,5-hydride shift in the "reverse" fashion (C-2 to C-9) to give the crucial 9-methyllongibornyl